Aflac Inc
Research Aflac Inc (AFL) on Bullrun: valuation model: 1.8% undervalued, market cap USD 57.53B, P/E 12.3, dividend yield 2.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAFL
- ExchangeNYSE
- CountryUnited States
- SectorFinancial Services
- IndustryInsurance-Life
- CurrencyUSD
- Valuation signal1.8% undervalued
- Market capUSD 57.53B
- P/E12.3
- Dividend yield2.1%
- Financial periodQ2 2026
- RevenueUSD 4.19B
- Net incomeUSD 825.00M
- Free cash flowUSD 112.00M
Valuation Snapshot
Bullrun's latest valuation model marks Aflac Inc as 1.8% undervalued; latest market cap is USD 57.53B; P/E is 12.3; dividend yield is 2.1%.
Peer valuation comparison
Latest P/E is 12.27x versus a Financial Services sector median of 13.39x (8.4% below).
Latest dividend yield is 2.08% versus a Financial Services sector median of 3.66% (43.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 17.16B | USD 3.65B | USD 2.56B | n/a | 6.82 | USD 6.25B | USD 8.41B | USD 29.49B |
| FY2024 | USD 18.93B | USD 5.44B | USD 2.71B | n/a | 9.63 | USD 6.23B | USD 7.50B | USD 26.10B |
| FY2023 | USD 18.70B | USD 4.66B | USD 3.19B | n/a | 7.78 | USD 4.31B | USD 7.36B | USD 21.99B |
| FY2022 | USD 19.14B | USD 4.42B | USD 3.88B | n/a | 6.93 | USD 3.94B | USD 7.44B | USD 20.14B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 57.53B | 12.3 | 2.1% | 2.41 |
| 2025 | 2025-12-31 | USD 57.20B | 16.0 | 2.1% | 2.32 |
| 2024 | 2024-12-31 | USD 56.89B | 10.8 | 1.9% | 2 |
| 2023 | 2023-12-29 | USD 48.21B | 10.9 | 2.0% | 1.68 |
| 2022 | 2022-12-30 | USD 44.73B | 8.8 | 2.2% | 1.6 |
| 2021 | 2021-12-31 | USD 38.08B | 9.2 | 2.3% | 1.32 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.41 USD, yield 2.1%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.35 USD |
| FY2024 | 2.08 USD |
| FY2023 | 1.76 USD |
| FY2022 | 1.62 USD |
About Aflac Inc
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States.
ETFs that hold Aflac Inc
Aflac Inc is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| Invesco Dow Jones US Insurance UCITS ETF USD Acc | 4.61% | 0.35% |
Related stock research
Other Financial Services stocks
Frequently asked questions
Is Aflac Inc overvalued or undervalued?
Bullrun's valuation model currently marks Aflac Inc as 1.8% undervalued.
What is Aflac Inc's market cap?
Aflac Inc's market capitalization is USD 57.53B.
What is Aflac Inc's P/E ratio?
Aflac Inc's price-to-earnings (P/E) ratio is 12.3.
Does Aflac Inc pay a dividend?
Aflac Inc has a dividend yield of 2.1%.
What does Aflac Inc do?
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States.